ArticleBioorganic & medicinal chemistry2016

Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.

Christopher K Arnatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.